Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex.

In previous immunohistochemical studies of monkey neocortex, we found that antisera directed against tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (DBH) appeared to label distinct populations of neocortical axons, which presumably were dopaminergic and noradrenergic, respectively. In the present study, we further evaluated the apparent selectivity of this rabbit anti-TH antiserum for cortical dopaminergic fibers in monkeys by comparing it with two other anti-TH antibodies, a mouse monoclonal and a sheep polyclonal. In addition, the latter two anti-TH antibodies were used in double-labeling studies with a rabbit anti-DBH antiserum. In both single- and dual-label studies, each anti-TH antibody visualized a similar population of cortical axons, although the number of labeled fibers differed across antibodies. That is, in some cortical regions and layers, both the sheep and mouse anti-TH antibodies labeled more cortical fibers than did the rabbit anti-TH antiserum. Thus, the former two antibodies appeared to identify a subpopulation of TH-containing fibers that the latter antibody did not. Dual-label experiments, involving the rabbit anti-DBH antiserum and either the sheep or mouse anti-TH antibodies, demonstrated numerous neocortical DBH-immunoreactive axons in which TH was not detectable immunohistochemically. The percentage of DBH-immunoreactive fibers that were single-labeled differed across cortical regions and with the anti-TH antibody employed. For example, in primary motor cortex the mouse anti-TH antibody did not label 99.4% of the DBH-positive fibers, whereas in primary visual cortex, 76.4% of the DBH-immunoreactive axons were identified by the sheep anti-TH antibody. The results of these studies indicate that many DBH-immunoreactive, presumably noradrenergic, axons in monkey neocortex are not visualized by anti-TH antibodies, and that the ability of anti-TH antibodies to identify noradrenergic cortical axons in monkeys differs substantially among anti-TH antibodies and across cortical regions. These findings may be consistent with previous reports suggesting that the TH molecule is present in different concentrations or molecular forms in dopaminergic and noradrenergic cortical fibers. Finally, this study demonstrates that the labeling characteristics of a particular anti-TH antibody must be carefully evaluated, particularly in studies of primate neocortex, in order to properly interpret the results of those studies.